This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Alchem gets EU antitrust charges for involvement in pharma cartel

( June 13, 2024, 09:45 GMT | Official Statement) -- MLex Summary: Alchem has been hit with antitrust charges by the European Commission, over suspicions that it participated in a long-lasting cartel to fix the minimum sales price of a pharmaceutical ingredient and to allocate quotas, the EU executive said in a statement today. The commission had already sanctioned other companies for involvement in the first EU-sanctioned pharmaceutical cartel, but unlike those companies, Alchem did not settle the case.See press statement....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections